Artia Global Partners LP has disclosed 46 total holdings in their latest 13F filing with the SEC for the portfolio
date of 2024-06-30. The current portfolio value is calculated to be $517.00 Mil. The turnover rate is 6%.
In Artia Global Partners LP's current portfolio as of 2024-06-30, the top 5 holdings are
Novo Nordisk A/S (NVO), Eli Lilly and Co (LLY), Merck & Co Inc (MRK), Viking Therapeutics Inc (VKTX), AstraZeneca PLC (AZN), not including call and put options.
Artia Global Partners LP did not buy any new stocks in the current portfolio.
Please visit the "Current Portfolio" tab to see the current and past 13F holdings for Artia Global Partners LP, as well as holding map,
valuations for each stock, which positions are undervalued, have low PE Ratios, are considered high quality and recently traded at
52-week lows, etc.
Please visit the "Stock Picks" tab to see the latest guru trades and stock picks for Artia Global Partners LP, which include data from
13F quarterly reports, 13D/G beneficial ownership reports and form 4 insider ownership change reports.
Please visit the "Summary" page to see the top 10 holdings, recent stock picks, performance, sector / industry breakdown details, as well as past holding history summary for Artia Global Partners LP.